Lili Wang

Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Xinghuai Sun, Mingzhi Zhang, J. Qu, 2012, Clinical therapeutics.

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis

Xinghuai Sun, Xiang-ge He, Mingzhi Zhang, 2012, Current medical research and opinion.

Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T‐cell lymphoma in a Chinese population: A multicenter phase II trial

Q. Cai, Mingzhi Zhang, Wei Song, 2022, American journal of hematology.